Genomics Market Size 2021-2028 | to Reach USD 94.66 Billion with

Key Players Covered in the Genomics Market Research Report are Illumina, Inc. (California, U.S.), Thermo Fisher Scientific Inc. (Massachusetts, United States), Pacific Biosciences of California, Inc. (California, U.S.), F. Hoffmann-La Roche Ltd. (Basel, Switzerland), Agilent Technologies, Inc. (California, U.S.), Oxford Nanopore Technologies (England, U.K.), Danaher (Washington, D.C., U.S.), QIAGEN (Hilden, Germany), BGI (Guangdong, China), IntegraGen (Evry, France), General Electric Company (Illinois, U.S.) and other key market players

Pune, India, Oct. 20, 2021 (GLOBE NEWSWIRE) — The global genomics market size is likely to reach USD 94.66 billion by 2028, registering a CAGR of 19.4% during the forecast period. Genomics abilities to manage, prevent and treat diseases majorly assist in precision medicine development. The use of whole-genome sequencing to diagnose serious diseases like cancer has turned out absolutely beneficial for the healthcare industry. Fortune Business Insights™ has presented this information in an upcoming report titled, “Genomics Market, 2020-2028”. The market size stood at USD 27.81 billion in 2021.

The report elucidates the different propellants aiding the market growth. For instance, the COVID-19 pandemic has had a positive impact on the genomics market. Researchers are using genomics to monitor coronavirus’s genome sequence, tracking the virus transmission, and understanding its impact on the human genome. This ongoing research activity is expected to propel the global genomics market growth in the forthcoming years.

COVID-19 Impact

The global pandemic has wreaked unprecedented havoc on several industries and markets. Healthcare systems are on the verge of collapsing in many nations. However, the coronavirus pandemic has augmented the genomics market growth due to the grave need for effective vaccine development and the continuous monitoring of the coronavirus. Investments in the research activities for developing effective COVID-19 treatment are augmenting the market growth. The global impact of the COVID-19 crisis is expected to gradually fade away as economies are trying to wade their way through the pandemic. It is uncertain to say how long the situation may persist this way. Nonetheless, our research report’s in-depth analysis will help you gain an exhaustive understanding of this niche market.

Story continues

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

Industry Developments

• December 2020: Personalis Inc., launched Neoantiigen Presentation Score (NEOPS) to predict and analyze the response to cancer therapy.

• August 2020: Ancestry launched AncestryHealth. It is able to identify genes related to colon cancer, heart diseases, breast cancer, etc., using next-generation sequencing.

Increasing Government Funding for Research Activities to Propel Future Growth

Personalized medicines help in providing effective treatment as per…